- Home
- SGMT vs FOA Comparison
SGMT vs FOA Comparison
Compare SGMT & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- FOA
- Stock Information
- Founded
- SGMT 2006
- FOA 2013
- Country
- SGMT United States
- FOA United States
- Employees
- SGMT N/A
- FOA N/A
- Industry
- SGMT
- FOA Finance Companies
- Sector
- SGMT
- FOA Finance
- Exchange
- SGMT Nasdaq
- FOA Nasdaq
- Market Cap
- SGMT 269.2M
- FOA 248.8M
- IPO Year
- SGMT 2023
- FOA N/A
- Fundamental
- Price
- SGMT $8.11
- FOA $23.59
- Analyst Decision
- SGMT Strong Buy
- FOA Buy
- Analyst Count
- SGMT 5
- FOA 2
- Target Price
- SGMT $26.60
- FOA $26.25
- AVG Volume (30 Days)
- SGMT 3.5M
- FOA 103.4K
- Earning Date
- SGMT 08-13-2025
- FOA 08-05-2025
- Dividend Yield
- SGMT N/A
- FOA N/A
- EPS Growth
- SGMT N/A
- FOA N/A
- EPS
- SGMT N/A
- FOA 3.94
- Revenue
- SGMT N/A
- FOA $429,184,000.00
- Revenue This Year
- SGMT N/A
- FOA $21.89
- Revenue Next Year
- SGMT N/A
- FOA $8.91
- P/E Ratio
- SGMT N/A
- FOA $5.83
- Revenue Growth
- SGMT N/A
- FOA 155.35
- 52 Week Low
- SGMT $1.73
- FOA $4.10
- 52 Week High
- SGMT $10.43
- FOA $32.40
- Technical
- Relative Strength Index (RSI)
- SGMT 60.20
- FOA 61.91
- Support Level
- SGMT $7.51
- FOA $22.41
- Resistance Level
- SGMT $8.61
- FOA $23.91
- Average True Range (ATR)
- SGMT 1.32
- FOA 0.89
- MACD
- SGMT -0.10
- FOA 0.16
- Stochastic Oscillator
- SGMT 47.92
- FOA 90.00
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.